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Introduction
Exposure to air pollution is a major public 
health concern and is associated with mor-
bidity and mortality from cardiorespiratory 
diseases (Brook et al. 2010). Indeed, on a 
population level, exposure to combustion-
derived particulate air pollution from traffic 
is recognized as a major trigger for myocardial 
infarction (Nawrot et al. 2011). With grow-
ing concern over the effects of exposure to air 
pollutants for the general public and suscepti-
ble patient populations, there is an increasing 
interest in defining the risks and underlying 
vascular and inflammatory mechanisms that 
may explain these observed associations.
The cardiovascular effects of air pollution 
are complex and include effects on vascular 
endothelial function, thrombosis, platelet 
function, and atherogenesis, as well as changes 
in blood pressure and cardiac autonomic con-
trol (Langrish et al. 2012a). Indeed, changes 
in autonomic control of the heart, measured 
by heart rate variability (HRV), have been 
widely studied in the air pollution literature, 
and a recent meta-analysis of 18,667 par-
ticipants enrolled in 29 studies reported an 
inverse relationship between measures of 
HRV and exposure to particulate air pol-
lution (Pieters et al. 2012). Reduced HRV 
represents a withdrawal of cardiac vagal 
tone or an increase in sympathetic tone and 
is a predictor of poor prognosis in patients 
recovering from myocardial infarction and 
in patients with cardiac failure (Task Force 
of the European Society of Cardiology and 
the North American Society of Pacing and 
Electrophysiology 1996) and may increase 
the risk of cardiac arrhythmias in these at-risk 
patients (Odemuyiwa et al. 1991). Recent 
evidence has linked activity of the autonomic 
nervous system and atrial electrical proper-
ties with the triggering of atrial arrhythmias 
such as atrial fibrillation (AF) and flutter 
(Arora 2012; Lo et al. 2011; Park et al. 2012). 
There is some limited  epidemiological evi-
dence linking exposure to air pollutants 
to both ventricu lar and supraventricular 
 arrhythmias (Brook et al. 2010), although 
these associations are not consistent (Gold and 
Mittleman 2013).
In the present study, we explored our 
database of continuous electro cardiographic 
(ECG) recordings made during controlled 
exposures to a range of air pollutants to deter-
mine whether there is evidence of an increase 
in the short-term risk of arrhythmia during 
such exposures.
Methods
Data were extracted from 13 consecutive 
randomized double-blind crossover studies 
including healthy volunteers and patients 
with coronary heart disease from 2004 to 
2013 (Table 1). All trials were reviewed and 
approved by the appropriate local ethics 
review boards of the NHS Research Ethics 
Service (Edinburgh, UK), Umeå University 
(Umeå, Sweden), or the Chinese Academy of 
Medical Sciences (Beijing, China). All par-
ticipants gave written informed consent in 
accordance with the Declaration of Helskini. 
All healthy volunteers had a normal 12-lead 
ECG and cardiovascular response to exer-
cise determined at screening. Patients with 
coronary heart disease were excluded if they 
had a history of arrhythmia, severe coronary 
disease without revascularization, signifi-
cant valvular heart disease or left ventricular 
systolic dysfunction, conduction abnormal-
ity on a resting 12-lead ECG, uncontrolled 
hypertension, or an acute coronary syndrome 
within the previous 3 months. Participants 
were exposed to a variety of air pollutants 
in controlled-exposure studies or in ambi-
ent settings [with the use of a highly efficient 
facemask to provide a control (Langrish et al. 
2009)]. Detailed monitoring of personal 
exposure was performed and continuous 
ECGs recorded to allow for the assessment of 
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Background: Epidemiological studies have reported associations between air pollution exposure 
and increases in cardiovascular morbidity and mortality. Exposure to air pollutants can influence 
cardiac autonomic tone and reduce heart rate variability, and may increase the risk of cardiac 
arrhythmias, particularly in susceptible patient groups.
oBjectives: We investigated the incidence of cardiac arrhythmias during and after controlled 
 exposure to air pollutants in healthy volunteers and patients with coronary heart disease.
Methods: We analyzed data from 13 double-blind randomized crossover studies including 
282 participants (140 healthy volunteers and 142 patients with stable coronary heart disease) from 
whom continuous electro cardiograms were available. The incidence of cardiac arrhythmias was 
recorded for each exposure and study population.
results: There were no increases in any cardiac arrhythmia during or after exposure to dilute diesel 
exhaust, wood smoke, ozone, concentrated ambient particles, engineered carbon nano particles, 
or high ambient levels of air pollution in either healthy volunteers or patients with coronary 
heart disease.
conclusions: Acute controlled exposure to air pollutants did not increase the short-term risk of 
arrhythmia in participants. Research employing these techniques remains crucial in identifying the 
important pathophysiological pathways involved in the adverse effects of air pollution, and is vital 
to inform environmental and public health policy decisions.
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cardiac arrhythmia (Barath et al. 2010; Cruts 
et al. 2008; Langrish et al. 2009, 2012b; Mills 
et al. 2005, 2007, 2008, 2011b).
In controlled-exposure studies, partici-
pants were exposed using a randomized, dou-
ble-blind controlled crossover design to either 
filtered air or to the experimental pollutant 
during intermittent exercise. The exposure 
time varied across these studies and is docu-
mented below. Each study visit was separated 
from the next by at least 7 days.
Control led and ambient exposure 
generation. Diesel-exhaust exposures. 
Controlled exposures to dilute diesel exhaust 
were performed in purpose-built exposure 
chambers in Umeå, Sweden (Mills et al. 2005), 
and in Edinburgh, United Kingdom, through 
a collaboration with the National Institute for 
Public Health and the Environment (RIVM), 
the Netherlands, as described previously (Mills 
et al. 2011b). In Sweden, diesel exhaust was 
produced by a diesel engine (model TD45, 
4.5 L, 4 cylinders; Volvo, Gothenburg, 
Sweden) under idling (Mills et al. 2005, 
2011b) or city-cycle conditions (Barath et al. 
2010). More than 90% of the exhaust was 
shunted away and the remainder mixed 
with filtered air and fed into a  purpose-built 
whole-body exposure chamber at steady-
state concentration. Air was sampled in the 
participant’s breathing zone and analyzed 
continuously for particle mass concentration, 
particle number concentration, oxides of 
nitrogen (NOx), carbon monoxide (CO), 
and total hydrocarbons (Mills et al. 2005). 
In Edinburgh, diesel exhaust was produced 
from a diesel electricity generator (4 cylinder, 
2.2 L, 500 rpm; Deutz, Cologne, Germany) 
and was diluted as above before being fed into 
a modified body-box exposure chamber (Mills 
et al. 2011b). The exposures were standardized 
with a target particulate matter mass 
concentration of 300 μg/m3. Participants were 
exposed to the diesel exhaust and filtered air for 
1 hr during intermittent exercise on a bicycle 
to generate an average minute ventilation of 
20 L/min/m2 body surface area.
Wood-smoke exposures. Wood smoke 
was generated using a common Nordic wood 
stove (chimney stove) in a controlled incom-
plete combustion firing procedure (Unosson 
et al. 2013). Birch wood logs with a moisture 
content of 16–18% were inserted every 
5–15 min to maintain a high burn rate with 
repeated air-starved conditions. The wood 
smoke was diluted with filtered air (HEPA 
filter and activated carbon filter) in three 
steps and continuously fed into a controlled 
environment exposure chamber (15.3 m3) 
to achieve a steady-state concentration. The 
atmosphere in the chamber was monitored 
for gaseous pollutants using continuous mea-
surement of NOx and CO. PM1 (particu-
late matter with an aero dynamic diameter of 
≤ 1 μm) mass concentration was measured 
on-line using a tapered element oscillat-
ing microbalance (TEOM 1400; Thermo 
Scientific, Waltham, MA, USA) equipped 
with a PM1 pre-cyclone. Integrated with the 
TEOM, a filter (Teflon) sampling line was 
used to determine the particle mass concen-
tration gravimetrically. The exposures were 
standardized with a target PM1 mass concen-
tration of 300 μg/m3 for 3 hr (n = 14) or 
1,000 μg/m3 for 1 hr (n = 15). As before, 
participants were exposed to wood smoke 
during intermittent exercise to generate an 
average minute ventilation of 20 L/min/m2 
body surface area.
Ozone (O3–) exposures. O3– was gen-
erated using an O3– generator (500 MM; 
Fischer Scientific, Schwerte, Germany) and 
the O3– concentration was measured continu-
ously in the participant’s breathing zone using 
a photometric O3– analyzer (model 1108; 
Dasibi Environmental Corp., CA, USA). 
During the exposures, ambient air was con-
tinuously drawn through the chamber at a 
ventilation rate of 30 m3/hr (Blomberg et al. 
1999). Temperature and relative humidity 
were maintained at 20°C and 50%, respec-
tively. The exposures were standardized to an 
O3– concentration of 300 ppb for 75 min. 
Again participants performed intermittent 
exercise during the exposure to maintain an 
average minute ventilation of 20 L/min/m2 
body surface area.
Concentrated ambient particle (CAP) 
exposures. A versatile aerosol concentration 
enrichment system (VACES) concentrator 
within a mobile ambient particle concentrator 
exposure laboratory sited outside the Royal 
Infirmary of Edinburgh (Edinburgh, UK), as 
used to deliver CAP exposures as described 
previously (Mills et al. 2008). Incoming 
ambient air (500 L/min) was saturated with 
water vapor to increase the size of ultrafine 
and fine particles before being passed through 
five parallel virtual impactors, each operating 
at 100 L/min. This increase in size, and there-
fore mass, ensured the particles had sufficient 
momentum to pass through the impactors, 
exiting in the minor flow (5 L/min) in which 
the particle concentration is enriched by a 
factor of 10- to 20-fold. The outward minor 
flow from the five impactors (25 L/min) was 
Table 1. Baseline characteristics and medical history of participants included in studies.
Parameter
Controlled exposure Ambient exposure
Diesel 
exhaust Wood smoke O3– CAPs
Engineered 
carbon NPs
Personal 
monitoring
Healthy volunteers
Baseline characteristics
No. of volunteers 80 29 15 17 14 14
Sex (male) 74 (93) 21 (72) 15 (100) 17 (100) 14 (100) 2 (14)
Age (years) 25 (18–24) 26 (20–35) 25 (22–30) 48 (21–69) 21 (20–44) 27 (20–45)
BMI (kg/m2) 24 ± 3 25 ± 4 NA 25 ± 3 23 ± 2 21 ± 2
Pulse (bpm) 65 ± 12 62 ± 13 68 ± 13 63 ± 10 74 ± 8 79 ± 3
SBP (mmHg) 138 ± 17 122 ± 14 150 ± 15 139 ± 20 132 ± 12 113 ± 8
DBP (mmHg) 72 ± 9 72 ± 8 74 ± 8 77 ± 8 68 ± 8 73 ± 6
Hemoglobin (g/dL) 147 ± 11 146 ± 9 148 ± 9 144 ± 10 148 ± 11 NA
Creatinine (μmol/L) 76 ± 12 78 ± 20 NA NA NA NA
Patients
Baseline characteristics
No. of patients 37 NA NA 12 NA 93
Sex (male) 33 (89) NA NA 12 (100) NA 80 (86)
Age (years) 63 (51–80) NA NA 59 (45–68) NA 63 (45–77)
BMI (kg/m2) 27 ± 3 NA NA 28 ± 3 NA 26 ± 3
Pulse (bpm) 57 ± 8 NA NA 53 ± 5 NA 67 ± 10
SBP (mmHg) 139 ± 20 NA NA 138 ± 10 NA 131 ± 17
DBP (mmHg) 77 ± 8 NA NA 80 ± 10 NA 79 ± 10
Hemoglobin (g/dL) 140 ± 11 NA NA 148 ± 7 NA 142 ± 11
Creatinine (μmol/L) 78 ± 12 NA NA 101 ± 12 NA 76 ± 16
Medical history
Previous MI 23 (62) NA NA 7 (58) NA 68 (73)
Diabetes mellitus 0 (0) NA NA 0 (0) NA 43 (46)
Hypercholesterolemia 25 (68) NA NA 12 (100) NA 40 (43)
Hypertension 8 (22) NA NA 4 (33) NA 75 (81)
Angina pectoris 14 (38) NA NA 5 (42) NA 65 (70)
Medication use
Aspirin 36 (97) NA NA 12 (100) NA 87 (94)
Clopidogrel 3 (8) NA NA 0 (0) NA 16 (17)
Beta-blocker 26 (70) NA NA 11 (92) NA 67 (72)
Statin 32 (87) NA NA 12 (100) NA 73 (79)
ACE inhibitor 13 (35) NA NA 1 (8) NA 28 (30)
Abbreviations: ACE, angiotensin-converting enzyme; BMI, body mass index; CAPs, concentrated ambient particles; 
DBP, diastolic blood pressure; MI, myo cardial infarction; NA, not applicable; NPs, nano particles; SBP, systolic blood 
 pressure. Values are expressed as n (%), mean ± SD, or median (IQR), as appropriate.
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desaturated by silica gel dryers to restore the 
particles to their original size, and diluted 
with filtered air before delivery into the 
human exposure chamber (50 L/min). Air 
was sampled in the participant’s breathing 
zone and analyzed continuously for tempera-
ture, humidity, particle mass concentration, 
particle number concentration, NOx, CO, 
sulfur dioxide (SO2), and O3– (Mills et al. 
2008). Participants were exposed to CAPs at 
a target concentration of 200 μg/m3 for 2 hr 
during intermittent exercise to generate an 
average minute ventilation of 20 L/min/m2 
body surface area.
Exposure to engineered carbon nano-
particles (NPs). An aerosol of carbon NPs 
was generated from graphite electrodes 
using an electric spark discharge generator 
(model CFG1000; Palas GmbH, Karlsruhe, 
Germany) in an atmosphere of pure argon. 
The output of the generator was mixed 
with filtered air, passed through an impac-
tor with a cutoff of 0.1 μm, and fed into a 
whole-body exposure chamber (Mills et al. 
2011b). Participants were exposed to the car-
bon particles for 2 hr with a target exposure 
of 4 × 106 particles/cm3 during intermittent 
exercise to generate an average minute ventila-
tion of 20 L/min/m2 body surface area.
Ambient exposures and personal moni-
toring. On two occasions in two randomized 
open-label controlled crossover studies, partici-
pants were randomized to wear no mask or a 
highly efficient occupational facemask (Dust 
Respirator 8812; 3M, St. Paul, MN, USA) 
as described previously (Langrish et al. 2009, 
2012b). The facemask visit was deemed the 
“control” visit for these analyses. Participants 
were asked to walk for 2 hr in a city center 
location in Beijing, China, between 0800 and 
1000 hours. Exposure to ambient air pollut-
ants was measured using portable monitor-
ing equipment mounted in a backpack. PM2.5 
mass (≤ 2.5 μm in aerodynamic diameter) and 
number concentrations, CO and SO2  levels, 
temperature, and humidity were recorded 
(Langrish et al. 2009). Physical activity was 
recorded using a global positioning system 
monitor within the backpack to ensure  exercise 
performed on each visit was equivalent.
Continuous ECGs and arrhythmia analy-
sis. Continuous ECGs were recorded from 
all participants (model 90217; Spacelabs 
Healthcare, Hertford, UK) during the expo-
sure and for the subsequent 24 hr, except in 
one diesel-exhaust study where the recordings 
were for 3 hr post exposure (n = 10) and one 
wood-smoke study where the recordings were 
for 8 hr post exposure (n = 14). Data were 
analyzed using the Pathfinder Digital 700 
Series Analysis System (Delmar Reynolds, 
Hertford, UK). Arrhythmias were identified 
using an automated algorithm and confirmed 
manually by trained operators.
Data analysis and statistics. The number 
of participants with observed arrhythmia was 
determined during the pollutant and con-
trol exposure periods and compared using 
the chi-square test, and odds ratios (ORs) 
were calculated. The numbers of arrhythmias 
per participant during pollutant and control 
exposure periods were compared using the 
Wilcoxon matched pairs signed rank test. 
All analyses were performed using GraphPad 
Prism (version 5 for Macintosh; GraphPad 
Software, San Diego, CA, USA). Statistical 
significance was taken as a two-sided p-value 
of < 0.05. Data are expressed as median 
[interquartile range (IQR)] or mean ± SD, as 
appropriate.
Results
We identified 282 participants (140 healthy 
volunteers and 142 patients with coronary 
heart disease; Table 1) who had been exposed 
to dilute diesel exhaust (n = 117) (Barath 
et al. 2010; Cruts et al. 2008; Mills et al. 
2005, 2007, 2011b), wood smoke (n = 29), 
O3– (n = 15), CAPs (n = 29) (Mills et al. 
2008), and engineered carbon NPs (n = 14) 
(Mills et al. 2011b) in controlled-exposure 
studies and ambient air pollution (n = 107) 
in Beijing, China (Langrish et al. 2009, 
2012b) (Table 2). The mean recording time 
was 22 ± 5 hr, and there were > 12,500 hr of 
ECG data in total.
There was no difference between the 
incidence of arrhythmias or the number 
of arrhythmias (Table 3, Figure 1) in each 
participant after any exposure as compared 
with filtered air (or in the case of the ambi-
ent exposures, an exposure in the presence 
of a highly efficient facemask). Similarly, 
there was no difference in the incidence or 
number of arrhythmias in the healthy vol-
unteer and patient subgroups when analyzed 
independently (see Supplemental Material, 
Tables S1 and S2). One patient with coro-
nary artery disease (73-year-old male with a 
past medical history of a previous myocardial 
infarction and hypertension, with a baseline 
blood pressure of 172/95 mmHg, who was 
taking aspirin, benazepril, bisoprolol, and 
simvastatin) had an asymptomatic episode of 
nonsustained AF lasting 15 sec while walking 
in central Beijing during his exposure visit 
(without a facemask). There were no other 
episodes of AF or flutter identified during the 
> 12,500 hr of continuous ECGs.
Discussion
We have compiled the single largest series of 
studies documenting continuous ECG moni-
toring in healthy volunteers and patients with 
stable coronary heart disease on appropriate 
medical therapy, who have been exposed to 
a diverse range of environmental air pollut-
ants in acute controlled-exposure studies. In 
> 12,500 hr of ECG data, we identified no 
evidence to suggest an increased tendency to 
arrhythmia after brief controlled exposures. 
These data indicate that there is no significant 
Table 2. Exposure parameters for air pollution exposures.
Exposure (min) Group
PM2.5  
(μg/m3)
PM10  
(μg/m3)
Particle count 
(× 104/cm3) CO (ppm) NOx (ppm) NO (ppm) NO2 (ppm) O3– (ppm) THC (ppm)
Diesel exhaust
60 (n = 64) HV NA 307 79 6.57 4.08 4.45 1.10 NA 3.0
60 (n = 37) Patients NA 294 103 3.82 3.29 2.46 0.83 NA 2.8
120 (n = 16) HV NA 363 120 3.50 0.60 0.40 0.20 NA NA
Ambient (median)
120 (n = 14) HV 86 NA 2.4 NA NA NA NA NA NA
120 (n = 93) Patients 89 NA 4.4 NA NA NA NA NA NA
Wood smoke
60 (n = 15) HV 895 (PM1) NA NA 15.32 NA 0.53 NA NA NA
180 (n = 14) HV 314 (PM1) NA NA 26.00 0.41 NA NA NA NA
O3–
75 (n = 15) HV NA NA NA NA NA NA NA 0.30 NA
CAPs
120 (n = 29) HV & patients NA 190 9.9 0.02 0.01 0.01 0.01 NA NA
Engineered carbon NPs
120 (n = 14) HV NA 70 387 NA NA NA NA NA NA
Abbreviations: HV, healthy volunteers; NA, not applicable; NO, nitric oxide; NO2, nitrogen dioxide; PM1, ≤ 1 μm in aerodynamic diameter; PM10, ≤ 10 μm in aerodynamic diameter; THC, 
total hydrocarbons. Values are expressed as mean, except as noted.
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risk of arrhythmia associated with controlled 
exposure to a wide range of air pollutants.
Air pollution and risk of arrhythmia. The 
epidemiological data linking exposure to air 
pollution and arrhythmia is limited. In a recent 
study conducted in Taipei, Taiwan, the total 
hospital admissions with cardiac arrhythmia 
over a 4-year period (> 16,000 hospital  visits) 
were associated with daily increases in PM 
air pollution (Chiu et al. 2013), although 
the investigators provided no information 
on the type of arrhythmias observed. Among 
patients with implantable cardiac defibrilla-
tors, some studies have reported an increase 
in ventricular arrhythmias with increasing 
exposure to particulate air pollutants (Dockery 
et al. 2005; Ljungman et al. 2008; Peters et al. 
2000; Rich et al. 2006). In a recent study of 
elderly patients with coronary heart disease, 
in which 20% of participants had a history of 
congestive cardiac failure, there was a small 
Table 3. Occurrence and number of arrhythmias in all participants (n = 282) included in the study (OR of arrhythmia occurring after pollutant exposure as 
compared with un exposed air controls).
Exposure; arrhythmia
No. of participants with 
documented arrhythmia
OR (95% CI) p-Value
No. of events per participant 
[median (IQR)]
p-ValueUnexposed Exposed Unexposed Exposed
Diesel exhaust (n = 117)
Pause 2 1 0.50 (0.04–5.55) 0.56 0 (0–0) 0 (0–0) > 0.99
Dropped beat 36 37 1.04 (0.60–1.81) 0.89 0 (0–1) 0 (0–1) 0.72
VT 1 0 0.33 (0.01–8.20) 0.32 0 (0–0) 0 (0–0) > 0.99
Salvo 1 4 4.11 (0.45–37.32) 0.18 0 (0–0) 0 (0–0) 0.56
Triplet 1 3 3.05 (0.31–29.80) 0.31 0 (0–0) 0 (0–0) > 0.99
Couplet 9 11 1.25 (0.50–3.13) 0.64 0 (0–0) 0 (0–0) > 0.99
Bradycardia 60 57 0.90 (0.54–1.51) 0.69 1 (0–57) 0 (0–35.5) 0.30
SVT 2 2 1.00 (0.14–7.22) 1.00 0 (0–0) 0 (0–0) > 0.99
AF 0 0 NA NA NA NA NA
Bigeminy 7 3 0.41 (0.10–1.64) 0.20 0 (0–0) 0 (0–0) 0.96
Trigeminy 4 4 1.00 (0.24–4.10) 1.00 0 (0–0) 0 (0–0) 0.50
VE 58 54 0.87 (0.52–1.46) 0.60 1 (0–4) 0 (0–4.5) 0.75
SVE 61 65 1.15 (0.69–1.92) 0.60 1 (0–6) 0 (0–4.5) 0.90
Ambient (n = 107)
Pause 0 0 NA NA NA NA NA
Dropped beat 1 2 2.02 (0.18–22.62) 0.56 0 (0–0) 0 (0–0) > 0.99
VT 1 2 2.02 (0.18–22.62) 0.56 0 (0–0) 0 (0–0) > 0.99
Salvo 1 2 2.02 (0.18–22.62) 0.56 0 (0–0) 0 (0–0) > 0.99
Triplet 1 0 0.33 (0.01–8.20) 0.32 0 (0–0) 0 (0–0) > 0.99
Couplet 9 4 0.42 (0.13–1.42) 0.15 0 (0–0) 0 (0–0) 0.24
Bradycardia 25 21 0.8 (0.42–1.54) 0.51 0 (0–0) 0 (0–0) 0.82
SVT 2 5 2.57 (0.49–13.57) 0.25 0 (0–0) 0 (0–0) 0.45
AF 0 1 3.03 (0.12–75.34) 0.32 0 (0–0) 0 (0–0) > 0.99
Bigeminy 16 18 1.15 (0.55–2.40) 0.71 0 (0–0) 0 (0–0) 0.80
Trigeminy 4 5 1.26 (0.33–4.84) 0.73 0 (0–0) 0 (0–0) 0.50
VE 87 86 0.94 (0.48–1.86) 0.86 7 (1–66) 7 (1–83) 0.52
SVE 86 88 1.13 (0.57–2.25) 0.73 5 (1–28) 6 (1–28) 0.25
CAPs (n = 29)
Pause 1 0 0.32 (0.01–8.24) 0.31 0 (0–0) 0 (0–0) > 0.99
Dropped beat 5 5 1.00 (0.26–3.91) 1.00 0 (0–0) 0 (0–0) 0.73
VT 0 0 NA NA NA NA NA
Salvo 1 0 0.32 (0.01–8.24) 0.31 0 (0–0) 0 (0–0) > 0.99
Triplet 2 4 2.16 (0.36–12.85) 0.39 0 (0–0) 0 (0–0) > 0.99
Couplet 2 3 1.56 (0.24–10.10 0.64 0 (0–0) 0 (0–0) > 0.99
Bradycardia 16 14 0.76 (0.27–2.13) 0.60 2 (0–33) 0 (0–28.5) 0.42
SVT 0 0 NA NA NA NA NA
AF 0 0 NA NA NA NA NA
Bigeminy 2 1 0.48 (0.04–5.64) 0.55 0 (0–0) 0 (0–0) > 0.99
Trigeminy 1 2 2.07 (0.18–24.24) 0.55 0 (0–0) 0 (0–0) > 0.99
VE 22 26 2.76 (0.64–11.96) 0.16 5 (0.5–34.5) 4 (2–28.5) 0.93
SVE 23 23 1.00 (0.28–3.56) 1.00 2 (1–8) 4 (1–13) 0.06
Wood smoke (n = 29)
Pause 2 0 0.19 (0.01–4.06) 0.15 0 (0–0) 0 (0–0) 0.50
Dropped beat 7 9 1.41 (0.44–4.51) 0.56 0 (0–0.5) 0 (0–1) 0.17
VT 0 0 NA NA NA NA NA
Salvo 0 0 NA NA NA NA NA
Triplet 0 0 NA NA NA NA NA
Couplet 0 0 NA NA NA NA NA
Bradycardia 18 18 1.00 (0.35–2.90) 1.00 3 (0–113) 5 (0–87.5) 0.32
SVT 0 0 NA NA NA NA NA
AF 0 0 NA NA NA NA NA
Bigeminy 1 0 0.32 (0.01–8.24) 0.31 0 (0–0) 0 (0–0) > 0.99
Trigeminy 1 0 0.32 (0.01–8.24) 0.31 0 (0–0) 0 (0–0) > 0.99
VE 19 15 0.56 (0.20–1.62) 0.29 0 (0–1) 0 (0–1) 0.07
SVE 17 14 0.66 (0.23–1.86) 0.43 3 (1–10.5) 2 (0–7.5) 0.79
Table continued
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increase in the risk of nonsustained ventricular 
tachycardia measured on ambulatory ECG 
with increasing exposure to PM air pollution 
(Bartell et al. 2013), although the same study 
did not find associations with changes in HRV 
or supraventricular arrhythmias. The finding 
of an increased risk of ventricular arrhythmia 
is, however, not consistent, and others have 
failed to show similar associations (Anderson 
et al. 2010; Metzger et al. 2007; Rich et al. 
2004; Vedal et al. 2004). In a recent long-term 
follow-up from the Normative Aging Study, 
short-term exposure to combustion-derived 
PM air pollution (measured as black carbon) 
was associated with an increased risk of ventri-
cular ectopy (Zanobetti et al. 2014). There is 
an association between air pollution exposure 
and the risk of hospitalization due to cardiac 
dysrhythmia (Colais et al. 2012; Santos et al. 
2008; Tsai et al. 2009) and out-of- hospital 
cardiac arrest (Rosenthal et al. 2013), although 
this may be confounded by the strong asso-
ciation between exposure and the triggering of 
myocardial infarction (Nawrot et al. 2011) or 
decompensation of patients with cardiac failure 
(Atkinson et al. 2013; Shah et al. 2013).
Although air pollution exposure is 
robustly linked to changes in cardiac auto-
nomic nervous system activity (Pieters et al. 
2012), which in turn may alter atrial electri-
cal properties and increase the risk of atrial 
arrhythmia (Arora 2012; Lo et al. 2011; 
Park et al. 2012), the association between 
air pollutant exposure and supraventricular 
arrhythmia is less robust. Among patients 
with coronary heart disease and elderly par-
ticipants, increasing exposure to PM air 
pollution increased the incidence of asympto-
matic runs of supraventricular arrhythmias 
Figure 1. Forest plots showing the risk of arrhythmias during and after exposure to air pollutants compared with a control air exposure (or in the presence of a 
highly efficient facemask for the ambient exposures). Abbreviations: SVE, supraventricular ectopy; SVT, supraventricular tachycardia; VE, ventricular ectopy; VT, 
ventricular tachycardia. p > 0.05 for all (chi-square analysis).
Diesel exhaust
Pause
Dropped beat
VT
Salvo
Triplet
Couplet
Bradycardia
SVT
AF
Bigeminy
Trigeminy
VE
SVE
Ambient CAPs Wood smoke Carbon NPs Ozone
–6 –4 –2 2 4 60 –6 –4 –2 2 4 60 –6 –4 –2
lnOR (95% CI)
2 4 60 –6 –4 –2 2 4 60 –6 –4 –2 2 4 60 –6 –4 –2 2 4 60
Table 3. Continued.
Exposure; arrhythmia
No. of participants with 
documented arrhythmia
OR (95% CI) p-Value
No. of events per participant 
[median (IQR)]
p-ValueUnexposed Exposed Unexposed Exposed
Engineered carbon NPs (n = 14)
Pause 0 0 NA NA NA NA NA
Dropped beat 14 12 0.17 (0.01–3.94) 0.14 6 (2.75–14) 6.5 (3.25–13.75) 0.88
VT 0 0 NA NA NA NA NA
Salvo 0 0 NA NA NA NA NA
Triplet 0 0 NA NA NA NA NA
Couplet 0 0 NA NA NA NA NA
Bradycardia 7 6 0.75 (0.17–3.32) 0.70 0.5 (0–64) 0 (0–26) 0.74
SVT 0 0 NA NA NA NA NA
AF 0 0 NA NA NA NA NA
Bigeminy 0 0 NA NA NA NA NA
Trigeminy 0 0 NA NA NA NA NA
VE 7 9 1.80 (0.40–8.19) 0.45 0.5 (0–7.25) 1 (0–5.5) 0.64
SVE 9 10 1.39 (0.28–6.84) 0.69 2.5 (0–5) 2 (0–5) 0.42
O3– (n = 15)
Pause 1 1 1.00 (0.06–17.63) 1.00 0 (0–0) 0 (0–0) > 0.99
Dropped beat 5 8 2.29 (0.52–10.01) 0.27 0 (0–1) 1 (0–4) 0.23
VT 0 0 NA NA NA NA NA
Salvo 0 0 NA NA NA NA NA
Triplet 0 0 NA NA NA NA NA
Couplet 0 0 NA NA NA NA NA
Bradycardia 12 11 0.69 (0.12–3.79) 0.67 18 (1–271) 14 (0–33) 0.12
SVT 0 0 NA NA NA NA NA
AF 0 0 NA NA NA NA NA
Bigeminy 0 0 NA NA NA NA NA
Trigeminy 0 0 NA NA NA NA NA
VE 12 8 0.29 (0.06–1.44) 0.25 2 (1–3) 1 (0–2) 0.21
SVE 9 12 2.67 (0.52–13.66) 0.23 1 (0–3) 1 (1–3) 0.86
Abbreviations: NA, not applicable; SVE, supraventricular ectopic beat; SVT, supraventricular tachycardia including AF; VE, ventricular ectopic beat; VT, ventricular tachycardia. 
Bradycardia is defined as HR < 50 bpm. Data expressed as n or median (IQR), as appropriate. p-Values and ORs from chi-square analysis and Wilcoxon matched-pairs signed rank test, 
as appropriate. 
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in two observational studies (Berger et al. 
2006; Sarnat et al. 2006). However, in a 
recent robust case-crossover study of > 10,000 
admissions to hospital with AF, there was no 
association with PM air pollution (Bunch 
et al. 2011). A more recent prospective 
analysis of patients with implantable cardiac 
defibrillators with established cardiac disease 
showed an increased risk of AF with acute 
increases in exposure to PM air pollution 
(Link et al. 2013). These contrasting findings 
may reflect the underlying individual suscep-
tibility to arrhythmia of the patients recruited 
into the trials. Positive associations have gen-
erally been in patients with established car-
diac disease, most notably cardiac failure who 
have structural abnormalities of the cardiac 
muscle and are generally at increased risk of 
developing cardiac dysrhythmias. Indeed, we 
have recently observed an increased risk of 
hospitalization and death with increasing PM 
air pollution exposure in patients with heart 
failure (Shah et al. 2013).
We previously reported that among 
32 healthy volunteers and 20 patients exposed 
to dilute diesel exhaust in controlled-exposure 
studies, there were no increases in cardiac 
arrhythmia or changes in HRV (Mills et al. 
2011a), and the findings from the present 
study are similar. Our screening procedures 
ensured all healthy volunteers were free from 
cardiac disease, and we excluded patients 
with coronary heart disease who had resting 
ECG abnormalities or a history of arrhyth-
mia. Therefore, we studied a relatively low-
risk population. We cannot exclude an effect 
of exposure to air pollutants in patients with 
overt cardiac failure who have conditional 
susceptibility to developing arrhythmias.
In their recent case report, Ghio et al. 
(2012) described a 58-year-old hyperten-
sive female volunteer with frequent atrial 
ectopy who developed sustained AF/flutter 
during exposure to CAPs. The authors sug-
gested a causal link; however, AF is the most 
common cardiac arrhythmia in the general 
population and is associated with increasing 
age, hypertension, and cardiac dysfunction 
and may be triggered by atrial ectopic beats 
originating from within the pulmonary veins 
(Haissaguerre et al. 1998). We suggest that 
it is more likely that the investigators simply 
witnessed an asymptomatic episode of AF in 
a patient at increased arrhythmic risk due to 
coexistent hypertension, age, and frequent 
atrial ectopy, and the occurrence of AF in 
the exposure chamber is likely to have been 
coincidence and simply due to chance. The 
short (< 0.25 min) single episode of asymp-
tomatic AF in > 750,000 min of ECG record-
ings in our studies is similarly likely to be due 
to chance in a patient at risk of arrhythmia 
due to poorly controlled hypertension and 
ischaemic heart disease.
Controlled-exposure studies. Air pollution 
research is challenging due to the ever- changing 
ambient concentrations and composition 
of the air pollution mixture. Controlled-
exposure studies in both animal models and 
humans have been employed to address 
fundamental questions necessary to understand 
the association between air  pollution exposure 
and acute cardio respiratory effects (Langrish 
et al. 2010). These studies remain crucial 
when it comes to identifying important 
pathophysiological pathways involved in the 
adverse effects of air pollution. Although there is 
some limited evidence of an association between 
exposure to PM air pollution and the risk of 
arrhythmia, particularly in at-risk populations, 
the individual risk during a short controlled-
exposure study is likely to be extremely small. 
We have shown that such studies do not 
increase the short-term risk of arrhythmia in 
healthy volunteers and patient groups thought 
to have an increased susceptibility to the adverse 
effects of air  pollution, such as those with 
chronic  respiratory  conditions and coronary 
heart disease.
Conclusions
Our data suggest that acute controlled 
 exposures to air pollutants are safe and do not 
significantly increase the short-term risk of 
arrhythmia among individuals at low risk of 
arrhythmia. Research employing these tech-
niques, when scientifically and ethically justi-
fied (National Research Council 2004; Rom 
et al. 2013), should continue and remains 
crucial in identi fying pathophysiological 
 pathways involved in the adverse effects of air 
pollution identified at the population level. 
These studies can be performed with mini-
mal risk and have the potential for substantial 
societal benefit, informing environmental and 
public health policy decisions.
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